185 related articles for article (PubMed ID: 15155165)
1. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications.
Khan SN; Lane JM
Expert Opin Biol Ther; 2004 May; 4(5):741-8. PubMed ID: 15155165
[TBL] [Abstract][Full Text] [Related]
2. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?
Szpalski M; Gunzburg R
Acta Orthop Belg; 2005 Apr; 71(2):133-48. PubMed ID: 16152845
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human bone morphogenetic proteins in the treatment of fractures.
Kain MS; Einhorn TA
Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
[TBL] [Abstract][Full Text] [Related]
6. Long-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates.
Schmitt PJ; Kelleher JP; Ailon T; Heller JE; Kasliwal MK; Shaffrey CI; Smith JS
Neurosurgery; 2016 Aug; 79(2):212-21. PubMed ID: 26702838
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins and spinal surgery.
Sandhu HS
Spine (Phila Pa 1976); 2003 Aug; 28(15 Suppl):S64-73. PubMed ID: 12897477
[TBL] [Abstract][Full Text] [Related]
8. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).
McKay WF; Peckham SM; Badura JM
Int Orthop; 2007 Dec; 31(6):729-34. PubMed ID: 17639384
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
12. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
[TBL] [Abstract][Full Text] [Related]
13. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
14. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein in spine surgery: current and future uses.
Even J; Eskander M; Kang J
J Am Acad Orthop Surg; 2012 Sep; 20(9):547-52. PubMed ID: 22941797
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Boden SD; Kang J; Sandhu H; Heller JG
Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
[TBL] [Abstract][Full Text] [Related]
17. Use of bone morphogenetic protein-2 for adult spinal deformity.
Luhmann SJ; Bridwell KH; Cheng I; Imamura T; Lenke LG; Schootman M
Spine (Phila Pa 1976); 2005 Sep; 30(17 Suppl):S110-7. PubMed ID: 16138058
[TBL] [Abstract][Full Text] [Related]
18. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
Stambough JL; Clouse EK; Stambough JB
Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
[TBL] [Abstract][Full Text] [Related]
19. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
20. Assessment of outcome following the use of recombinant human bone morphogenetic protein-2 for spinal fusion in the elderly population.
Shweikeh F; Hanna G; Bloom L; Sayegh ET; Liu J; Acosta FL; Drazin D
J Neurosurg Sci; 2016 Jun; 60(2):256-71. PubMed ID: 25027648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
